FDA OKs Drug Linked to Longer Survival in Fatal Genetic Disorder | HappeningNow.news

Health · 2 views

FDA OKs Drug Linked to Longer Survival in Fatal Genetic Disorder

Source Summary Published 2h 29m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 2 Community interest
Brief read Under 1 min brief 26 words

Summary

(MedPage Today) -- The FDA approved adrabetadex (Lembaz) injection on Tuesday for patients with infantile-onset Niemann-Pick disease type C (NPC), a rare and fatal genetic disorder.

Read original at MedPage Today

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page